Free Cash Flow

Chembio Diagnostics, Inc. (CEMI)

$ 2.385
-0.03 (-1.04%)

Free Cash Flow

Year
A/P
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 17.8724.0233.4134.4630.4535.4041.1647.8555.6364.67
Revenue (%)
Operating Cash Flow -6.70-5.03-11.78-9.06-18.89-12.89-14.99-17.42-20.25-23.55
Operating Cash Flow (%)
Capital Expenditure -0.12-1.03-1.47-3.80-4.17-2.41-2.80-3.26-3.79-4.40
Capital Expenditure (%)
Free Cash Flow -6.82-6.06-13.25-12.86-23.05-15.30-17.79-20.68-24.04-27.95

FCF Unlevered from cash flow statement